EU Commission concludes exploratory talks with BioNTech-Pfizer to purchase COVID-19 vaccine
|The European Commission has concluded exploratory talks with BioNTech-Pfizer to purchase a potential vaccine against COVID-19, Reuters reported on Wednesday.
Pfizer and BioNTech will reportedly supply the EU with 200 million doses of mRNA-based vaccine candidate against coronavirus.
The company added that it currently plans to supply up to 100 million doses worldwide by the end of 2020 and approximately 1.3 billion doses by the end of 2021.
Market reaction
This headline doesn't seem to be having a significant impact on market sentiment or the shared currency's performance against its rivals. As of writing, the EUR/USD pair was down 0.12% on the day at 1.1764. Meanwhile, the Euro Stoxx 50 and Germany's DAX 30 were both gaining around 0.9% on a daily basis.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.